Shanjun Dai

No ORCID on file · 5 papers in corpus
observational 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1473854

BACKGROUND: To compare the clinical outcomes between frozen-thawed cleavage embryo transfer and frozen-thawed day 6 blastocyst transfer in patients younger than 35 using the freeze-all strategy without day 5 blastocyst formation. METHODS: …

2020
·doi:10.21203/rs.3.rs-64858/v1

Abstract Persistent supraphysiological serum estradiol (E2) levels during controlled ovarian hyper-stimulation (COH) have a detrimental effect on endometrial receptivity. In this study, we explored RNA expression and DNA methylation profile…

observational 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.615957

INTRODUCTION: Age, polycystic ovary syndrome (PCOS), low body mass index (BMI), high antral follicle count (AFC), increased anti-Muller hormone (AMH) levels, and elevated serum estradiol (E2) concentrations are risk factors for ovarian hype…

observational 2020
Aging ·doi:10.18632/aging.103151

We investigated the effects of paternal characteristics, including age, body mass index (BMI), and semen parameters on chromosomal aberration-related miscarriages in couples that underwent treatment with assisted reproductive technology (AR…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00834

Background: Polycystic ovary syndrome (PCOS) patients have a better ovarian reserve and age-related improvement in endocrine disturbances than non-PCOS patients. The effects of age on in vitro fertilization (IVF) treatment outcomes associat…